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Abstract
Background: There is an urgent need to develop safe and effective adjuvants for the new generation of subunit
vaccines. We developed the tubular immunostimulating complex (TI-complex) as a new nanoparticulate antigen
delivery system. The morphology and composition of TI-complexes principally differ from the known vesicular
immunostimulating complexes (ISCOMs). However, methodology for the preparation of TI-complexes has suffered a
number of shortcomings. The aim of the present work was to obtain an antigen carrier consisting of triterpene
glycosides from Cucumaria japonica, cholesterol, and monogalactosyldiacylglycerol from marine macrophytes with
reproducible properties and high adjuvant activity.
Results: The cucumarioside A2-2 - cholesterol - MGalDG ratio of 6:2:4 (by weight) was found to provide the most
effective formation of TI-complexes and the minimum hemolytic activity in vitro. Tubules of TI-complexes have an
outer diameter of about 16 nm, an inner diameter of 6 nm, and a length of 500 nm. A significant dilution by the
buffer gradually destroyed the tubular nanoparticles. The TI-complex was able to increase the immunogenicity of
the protein antigens from Yersinia pseudotuberculosis by three to four times.
Conclusions: We propose an optimized methodology for the preparation of homogeneous TI-complexes
containing only tubular particles, which would achieve reproducible immunization results. We suggest that the
elaborated TI-complexes apply as a universal delivery system for different subunit antigens within anti-infectious
vaccines and enhance their economic efficacy and safety.
Background
Immunostimulating complexes (ISCOMs) are a com-
monly known adjuvant that represents a supramolecular
combination of saponins from Quillaja saponaria,c h o -
lesterol, and phosphatidylcholine. It has been shown
that ISCOMs display high adjuvant activity against a
broad range of bacterial and viral antigens [1-5]. How-
ever, the side effects of ISCOMs are their toxicity,
caused by the presence of the hemolytic saponins of Q.
saponaria [2,6], a consistently insufficient adjuvant
activity, and the absence of a satisfactory method of
preparing them for industrial applications [6-9]. The
development of the ISCOMATRIX™ adjuvant, based on
purified saponin fractions from Quil A substantially
overcomes these shortcomings [1,10]. However, we pro-
posed principally new biologically active components,
glycoglycerolipids and triterpene glycosides isolated
from marine macrophytes and invertebrates, respec-
tively, to modify and optimize ISCOM vehicles for
microbial antigens. The immunologically inert phospho-
lipid phosphatidylcholine (PC) of ISCOMs was replaced
by glycolipid monogalactosyldiacylglycerol (MGalDG)
from marine macrophytes (algae and seagrasses) [11].
Subsequent substitution of the sum of saponins from Q.
saponaria by triterpene glycosides from sea cucumbers,
possessing immunostimulating activity, resulted in a
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instead of the vesicular one of classical ISCOMs [12].
Based on these results, we developed a prototype of TI-
complex consisting of the sum of monosulfated triter-
pene glycosides from Cucumaria japonica,c h o l e s t e r o l ,
and MGalDG from marine macrophytes with a compo-
nent weight ratio of 3:2:6, respectively. To obtain an
antigen carrier, we further developed a method [13]
based on that proposed earlier by Copland et al. [7].
Biological tests of the TI-complex prototype revealed
that it had adjuvant activity [14-16].
However, these pilot preparations of TI-complexes
appeared to be heterogeneous with a large amount of
source material (amorphous phase of MGalDG + cho-
lesterol), and intermediate structures apart from the
complex particles. Perhaps this was a cause of non-
reproducible and often contradictory immunization
results. The presence of intermediate structures was also
characteristic of classical ISCOM preparations obtained
by methods of dialysis [17], the hydration of lipid films
[7], and the injection of diethyl ether [9]. The aim of the
present work was to obtain an antigen carrier based on
triterpene glycosides from C. japonica,c h o l e s t e r o l ,a n d
MGalDG from marine macrophytes with reproducible
properties and high adjuvant activity. The practical part
of the work is protected by Application № 2010122159/
10(031466) for Patents of the Russian Federation [18].
Results and Discussion
Immunological properties of the prototype TI-complex
TI-complexes consisting of the sum of monosulfated tri-
terpene glycosides from Cucumaria japonica,c h o l e s -
terol, and MGalDG from marine macrophytes with a
component weight ratio of 3:2:6 was used as prototype.
It was observed that the thermally denatured mono-
meric porin from Yersinia pseudotuberculosis was effec-
tively (not less than 95%) incorporated into TI-complex
[15]. Immunization of mice with this protein antigen in
TI-complexes provided stronger humoral immune
response than one with porin in ISCOMs and Freund’s
complete adjuvant (Figure 1). Interestingly, the substitu-
tion of non-lamellar MGalDG for lamellar-prone PC in
TI-complexes resulted in the lower immune response
compared with the original TI-complex. Immunization
with pure porin at doses of 0.1-10 μg/mouse did not
reveal dose-dependent immune response, which was
probably related to the immunosuppressive effect of
porin at doses above 0.1 μg/mouse. The incorporation
of antigen in TI-complex resulted in an increase in
immune response only at these high doses, which may
have been due to the deposition of antigen and the
decrease in its immunosuppressive action (Figure 2).
T h ep u r ep o r i na td o s e so f0 . 1a n d1μg/mouse also
inhibited the production of INF-g, which is a classical
Th1 cytokine [19] (Figure 3A). The introduction of
porin incorporated in TI-complexes resulted in the sub-
stantial enhancement of the INF-g concentration. Con-
centration of another proinflammatory cytokine, IL-1b,
[20] also increased (about three-fold) in immunization
results with the same antigen incorporated in TI-
complexes compared with pure porin (Figure 3B).
These results showed the bioavailability of TI-
complexes as a new type of promising adjuvant carrier
for antigens, although adjuvant activity of TI-complexes
with a component weight ratio of 3:2:6 was not suffi-
ciently high.
The Choice of optimum composition for the TI-complex
formation
We obtained chromatographically pure cucumarioside
A2- 2f r o mt h es u mo ft h et r i t e r p e n eg l y c o s i d e so fC.
japonica and identified its structure by
13C NMR [21]. It
is advantageous to use pure cucumarioside A2-2 rather
than the sum of monosulfated triterpene glycosides,
because it exhibits the highest immunostimulatory
Figure 1 Effect of different adjuvants on relative antibody
response to porin YompF. Along the ordinate, percentages with
respect to the value for an anti-porin reference serum (serum of
mice immunized with pure porin). Along the horizontal axis, the
experimental group of animals immunized with: FCA+porin - porin
mixed with Freund’s complete adjuvant (Sigma); ISCOM+porin -
porin incorporated in ISCOMs, prepared as described [11]; TI(PC)
+porin - porin incorporated in TI-complex consisting of a
cucumarioside A2-2, cholesterol and PC from egg yolk at weight
ratio of 3:2:6; TI+porin - porin incorporated in TI-complexes
consisting of a cucumarioside A2-2, cholesterol and MGalDG from
Ulva fenestrata at weight ratio of 3:2:6. Dose of antigen (denaturated
monomeric porin YompF) - 10 μg/mouse.
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sive di- and tri-sulfated triterpene glycosides of C. japo-
nica [22] in TI-complexes is avoided.
Energy-filtered transmission electron microscopy
(EFTEM) was applied to unstained samples to investi-
gate the homogeneity of the preparations of TI-com-
plexes prepared with pure cucumarioside A2-2. The
structure of the particles of the TI-complex was studied
in samples that were negatively stained by phospho-
tungstic acid.
Micrographs of negatively stained samples (Figure 4A)
of the prototype TI-complex cucumarioside A2-2 - cho-
lesterol - MGalDG, with a component weight ratio of
3:2:6, indicated the presence of typical tubular nanoparti-
cles [13]. However, the unstained samples contained a
substance that was not included in the tubular particles,
probably representing excess MGalDG and cholesterol
(Figure 4B). The two-fold smaller proportion of cucumar-
ioside A2-2 in the cucumarioside A2-2 - cholesterol -
MGalDG ratio (1.5:2:6) led to a sharp increase in the
amount of a substance not included in the tubular parti-
cles (Figure 4D), whereas the negatively stained samples
displayed a large number of typical tubular structures
(Figure 4C). The two-fold increased (6:2:6) presence of
cucumarioside A2-2 in the cucumarioside A2-2 - choles-
terol - MGalDG ratio led to a more homogeneous system
than in the prototype (Figure 4F), while the tubular struc-
ture of the particles persisted (Figure 4E). A further
reduction in the MGalDG of cucumarioside A2-2 - cho-
lesterol - MGalDG ratio to 6:2:4 led to the formation of a
homogeneous system containing only particles with a
typical tubular structure (Figure 4G) and it contained
almost no extraneous substances (Figure 4H). The
increase of MGalDG in the system up to 6:2:10 led to the
appearance of a substance not included in the tubular
structures (Figure 4J) in comparison with the cucumario-
side A2-2 - cholesterol - MGalDG ratio of 6:2:6, while
the tubular structure persisted (Figure 4I).
Thus, a cucumarioside A2- 2-c h o l e s t e r o l-M G a l D G
ratio of 6:2:4 (Figures 4G, H) prevented the formation of
any particle other than the tubular type. This weight ratio
of the components of the TI-complex was equimolar.
Hemolytic activity of TI-complex
Study of the hemolytic activity of TI-complex prepara-
t i o n s( T a b l e1 )r e v e a l e dt h a tt h ec u c u m a r i o s i d eA 2-2 -
cholesterol - MGalDG complex with a ratio of 6:2:4
Figure 2 Effect of TI-complex on the content of anti-porin
antibodies at different doses of porin YompF. Along the
ordinate, optical density at 450 nm. Along the horizontal axis,
experimental groups of animals immunized with: PBS - phosphate-
buffered saline, Porin 0.1/1/10 - pure denaturated monomeric porin
YompF at a dose of 0.1/1/10 μg/mouse, TI+porin 0.1/1/10 -
denaturated monomeric porin YompF (a dose - 0.1/1/10 μg/mouse,
respectively) incorporated in TI-complexes consisting of a
cucumarioside A2-2, cholesterol and MGalDG from Ulva fenestrata at
weight ratio of 3:2:6.
Figure 3 Effect of TI-complexes on concentration of INF-g (A)
and IL-1b (B) at different doses of porin YompF. Experimental
groups of animals immunized with: PBS - phosphate-buffered saline,
Porin 0.1/1 - pure denaturated monomeric porin YompF at dose of
0.1/1 μg/mouse, TI+porin - denaturated monomeric porin YompF (a
dose - 0.1 or 1 μg/mouse, respectively) incorporated in TI-
complexes consisting of a cucumarioside A2-2, cholesterol and
MGalDG from Ulva fenestrata at weight ratio of 3:2:6.
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ing proportions of MGalDG in the TI-complex were
accompanied by an increase in its hemolytic activity,
because this glycolipid alone showed its own hemolytic
activity.
Optimal dilution of the TI-complex preparations
Investigation of the stability of the TI-complexes
revealed that dilution of the original preparations of the
complex prototype with PBS led to a gradual destruction
of the tubular nanoparticles and increased the amount
of substance that was not included in the tubular struc-
tures (Figure 5). The five-fold dilution did not result in
initial signs of destruction of the complex (Figure 5B),
whereas the 75-fold dilution led to an almost complete
destruction of the TI-complex (Figure 5D). This
seems to be responsible for the low reproducibility of
the immunization results by the prototype of the TI-
complex [13,14], since the original preparation of the
complex was diluted 75 times with phosphate buffer at
immunization.
The TI-complex with a cucumarioside A2-2 - choles-
terol - MGalDG component weight ratio of 6:2:4 diluted
10-folds with phosphate buffer was selected for the bio-
logical tests. The volume of the preparation for immuni-
zation was 10 μl per mouse. A further decrease in the
dilution of the TI-complex in order to reduce its
destruction was impossible, since the injection of less
than 10 μl is technically difficult.
Immunostimulating activity of TI-complex
The antibody response is the main indicator of adjuvant
properties of any immunostimulating complexes or
Figure 4 Electron micrographs of the TI-complexes with
different weight ratio of the components. The ratios of
cucumarioside A2-2 - cholesterol - MGalDG: A, B - 3:2:6; C, D -
1.5:2:6; E, F - 6:2:6; G, H - 6:2:4; I, J - 6:2:10. I - TEM micrographs of
negatively stained samples, bar is 100 nm. II - EFTEM micrographs of
unstained samples, bar is 200 nm.
Table 1 Hemolytic activity (concentration causing 50%
hemolysis of red blood cells - HD50) of TI-complexes and
their components
Individual
components of
TI-complex
TI-complexes with different
ratios of cucumarioside
A2-2 - cholesterol - MGalDG
HD50,
μg/ml
Cucumarioside A2-2 0.8
Saponins of Quillaja
saponaria
25.0
MGalDG from Zostera
marina
44.2
MGalDG from
Sargassum pallidum
47.6
6-2-15
a) 13.6
6-2-15
b) 47.6
3-2-6
a) 43.0
3-2-6
b) 60.8
6-2-4
a) 71.9
6-2-4
b) 109.2
a) MGalDG from Zostera marina;
b) MGalDG from Sargassum pallidum
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pore-forming YompF-protein from the outer membrane
of Y. pseudotuberculosis cells in the TI-complex was sig-
nificantly more immunogenic than when in pure form,
as observed in a four-fold increase in optical density in
ELISA for the trimeric forms of YompF, incorporated
into the TI- complex (Figure 6A).
To confirm the adjuvant activity of the TI-complex,
thermostable toxin (TST) from the same bacterium was
also used [24]. Experiments addressing the immuniza-
tion of mice with TST revealed that the injection of
TST at a dose of 0.1 μg per mouse in the 6:2:4 TI-com-
plex resulted in a three-fold increase in optical density
in ELISA in comparison with the free antigen, indicating
a significant adjuvant effect of the TI-complex with
respect to TST (Figure 6B).
Conclusions
In this work, we have determined the optimum ratio
of components (cucumarioside A2-2, cholesterol and
MGalDG) to form maximally homogeneous TI-com-
plexes with minimal toxicity. The evidence of the com-
plex destruction at the high dilution is also important to
achieve reproducible immunization results. The data
from biological tests revealed that the TI-complex can
serve as a powerful adjuvant for subunit bacterial
antigens.
Methods
Cucumarioside A2-2 isolation
Cucumarioside A2-2 was isolated by a modified method
[21,22]. The body wall of the holothurian Cucumaria
japonica (3 kg) was extracted twice for 3 h with an
equal volume of 50% ethanol under conditions of boil-
ing. The extracts thus obtained were combined and eva-
porated to dryness by the addition of 20% n-butanol.
80 g of the resulting extract was dissolved in 1.5 L of
distilled water and the sum of triterpene glycosides and
sterols was obtained by reverse phase chromatography
using a column with 0.5 kg of Polichrom-1 (fraction of
Figure 5 Destruction of the TI-complex when diluted with phosphate buffer. The weight ratio of cucumarioside A2-2 - cholesterol -
MGalDG was of 3:2:6. A - An initial complex, scale bar: 200 nm; B - 5-fold diluted, scale bar: 200 nm; C - 10-fold diluted, scale bar: 200 nm; D -
75-fold diluted, scale bar: 100 nm. Negative staining.
Kostetsky et al. Journal of Nanobiotechnology 2011, 9:35
http://www.jnanobiotechnology.com/content/9/1/35
Page 5 of 90.5-1 mm) purchased from “Biolar”, Latvia. The column
length to diameter ratio was 5:1. The column was
washed with distilled water up to a negative reaction for
the chloride ion. The sum of triterpene glycosides and
sterols was eluted with 50% ethanol. The yield of the
substances was monitored by TLC on silica gel with
chloroform-ethanol-water at 100:100:17 (v/v). The plates
were sprayed with a solution of 10% sulfuric acid in
methanol, followed by heating at 150°C until dark spots
appeared.
For further removal of macromolecular impurities,
the fraction was evaporated to dryness (3 g), and
then repeatedly extracted with systems of chloroform-
ethanol-water 100:75:10 and 100:100:17 (v/v). The
extracts were combined, evaporated to dryness (1.5 g),
and re-dissolved in a minimum volume of chloroform-
ethanol-water at 100:100:17 (v/v).
Sterols and sterol sulfates were separated on a silica
gel (100/160 μm fraction, Chemapol, Czech Republic)
column (the ratio of length to diameter was 10:1) equili-
brated with chloroform-ethanol 3:1 (v/v). The sorbent-
substance ratio was 100:1. The column was eluted with
chloroform-ethanol 3:1 (v/v). After separation of the
sterols (750 mg), the triterpene glycosides were eluted
with chloroform-ethanol-water at 100:100:17. The yield
of substances was monitored by TLC as described
above. Fractions corresponding to the sum of monosul-
fated triterpene glycosides were pooled and evaporated
to dryness (450 mg). Then, the sum of monosulfated tri-
terpene glycosides was separated on a silica gel (40-63
μm, Merck, Germany) column (length to diameter ratio
10:1), equilibrated with chloroform-ethanol-water
100:100:17 (v/v). The sorbent - triterpene glycoside ratio
was 150:1. The substances were eluted with the same
system. Fractions corresponding to cucumarioside A2-2
(control by TLC using a standard of cucumarioside A2-
2) were combined and evaporated to dryness (200 mg).
Cucumarioside A2-2 was isolated by preparative
reverse phase HPLC-MS followed by HPLC-MS on silica
gel. This was performed with a SHIMADZU LC-8A
chromatograph. Substance output was detected in nega-
tive ion mode at 3 kV using an HPLC LCMS - 2010EV
mass spectrometer. Reverse phase chromatography was
performed on a Sim-pack PREP-ODS (20 × 250 mm)
column. 1.5 ml of an aqueous solution of the sum of tri-
terpene glycosides at a concentration of 10 mg/ml was
injected into the column and eluted with a methanol-
water gradient of 70% - 20 min; 75% - 20 min, and 90%
- 40 min at a rate of 10 ml/min. The fraction corre-
sponding to ion m/z of 1299 was selected. HPLC was
performed on a PREP-sil silica gel Sim-pack column
(20 × 250 mm). 2 ml of the triterpene glycosides at a
concentration of 5 mg/ml in a 73.2:22.95:3.8 (v/v)
chloroform-methanol-water system was injected into
column and eluted with the same system at a rate of 10
ml/min. The selected fraction, corresponding to ion m/z
of 1299, was a pure cucumarioside A2-2 (80 mg).
The structure of purified cucumarioside A2-2 in deu-
teropyridine was identified by
13C NMR spectroscopy
on a Brucker-500 spectrometer. The spectrum was iden-
tical to that previously published for cucumarioside
A2-2 [22,25].
Isolation of monogalactosyldiacylglycerol
MGalDGs from marine macrophytes were isolated and
their fatty acid analysis was performed as described
previously [26]. Chromatographically pure MGalDG
was dissolved in chloroform and stored at -20°C in a
light-proof container.
Preparation of TI-complexes
To obtain the TI-complex with a cucumarioside A2-
2-cholesterol-MGalDG component ratio of 6:2:4, 5 mg
of MGalDG was dissolved in 1 ml of chloroform; 5 mg
of cholesterol was dissolved in 1 ml of chloroform; and
4 mg of cucumarioside A2-2 was dissolved in 1 ml of
distilled water. Then, a 66-μl solution of MGalDG and a
33-μl solution of cholesterol were evaporated to dryness
under a stream of air at a temperature of 60°C. A 125-μl
Figure 6 Content of specific antibodies to the thermostable
toxin (A) and YompF (B) from Yersinia pseudotuberculosis.
Along the ordinate, optical density at 450 nm. Along the horizontal
axis, the experimental group of animals immunized with: PBS -
phosphate-buffered saline, TST - pure thermostable toxin, TST + TI -
thermostable toxin in the TI-complex, TP - trimeric form of YompF,
TP + TI - trimeric form of YompF in the TI-complex. TI-complexes
comprised of a cucumarioside A2-2, cholesterol and MGalDG from
Ulva fenestrata at weight ratio of 6:2:4.
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residue. Then, 375 μlo fP B S ,p H7 . 2 ,w a sa d d e dt ot h i s
mixture, adjusting the concentration of MGalDG and
cholesterol to 1 mg/ml. The suspension thus obtained
was sonicated for 5 min on a SONOPULS Ultrashall-
Homogenizatoren HD 2070 (Germany) ultrasonic disin-
tegrator at 10% maximum power (0.7 sec - work; 0.3 sec
- interval). After sonication, the preparation was left to
stand at room temperature for 2 h.
To obtain the TI-complexes with other component
ratios, the volume of the aliquots of the components
was increased or decreased. However, the final volume
of the preparation was always 0.5 ml and the total con-
centration of MGalDG and cholesterol was 1 mg/ml.
To obtain the YompF-containing TI-complex with 0.1
μgo fp r o t e i np e r1μg of cucumarioside A2-2, 100 μlo f
the lipid-saponin complex was collected immediately
after sonication and combined with a 10-μl YompF solu-
tion in PBS, pH 7.2, at a concentration of 1 mg/ml. This
mixture was vortexed for 1 min. Then, the preparation
was left to stand at room temperature for 2 h.
The complex containing thermostable toxin (TST) was
prepared in a similar way to the complex containing
YompF. To obtain the complex with 0.1 μgT S Tp e r1
μg of cucumarioside A2-2, 75 μl of lipid-saponin com-
plex was collected and added to 25 μl of the TST solu-
tion in PBS, pH 7.2, at a concentration of 0.3 mg/ml.
To study immunological properties of the TI-complex
prototype, the complex of monosulfated triterpene glyco-
sides from C. japonica, cholesterol and MGalDG from
Ulva fenestrata (or PC from egg yolk) were mixed at the
weight ratio of 3:2:6. Then denaturated monomeric porin
from Y. pseudotuberculosis at a respective dose (0.1, 1 or
10 μg of protein per 1 μg of glycosides) was added to
TI-complexes. The resulted mixture was sonicated
by ultrasonic disintegrator SONOPULS Ultrashall-Homo-
genizatoren HD 2070 (Germany) at 10% maximum
power (0.7 sec - work; 0.3 sec - interval) [13-15]. Porin-
containing ISCOMs were prepared as described [11].
Trimer and denatured monomer forms of YompF
were isolated from Y. pseudotuberculosis (strain 598, I
serovar) by researchers at the Laboratory of the Molecu-
lar Bases of Antibacterial Immunity, PIBOC, FEB RAS
following a method [27]. Thermostable toxin [24] was
provided by collaborators at Laboratory of the Molecu-
lar Bases of Bacterial Pathogenicity at the Research
Institute of Epidemiology and Microbiology, SB RAMS.
Transmission electron microscopy
Transmission electron microscopy (TEM) and energy-
filtered transmission electron microscopy (EFTEM) were
performed with Libra-120 microscope (Zeiss, Germany)
at an accelerating voltage of 120 kV. Each suspension of
the TI-complexes was investigated by TEM on the
negatively stained samples and by EFTEM on the
unstained samples. Copper grids of 300-400 mesh with
a formvar substrate were used to prepare the samples
[28].
To prepare the samples, 1-2 μl of a TI-complex sus-
pension was placed on a grid and then dried in a stream
of warm air. The dried grid was washed three times
with 3 μl of distilled water, removing the excess with fil-
ter paper. To prepare the unstained samples, the washed
grids were dried in a stream of warm air. To obtain the
negative stained samples, 1 μl of a 0.5% solution of
phosphotungstic acid, pH 7.2, was placed on the washed
grid and then dried in a stream of warm air.
Hemolytic activity
The hemolytic activity of the TI-complexes was deter-
mined by a direct hemolysis reaction. A 0.5% suspension
of human erythrocytes in 0.01 M PBS, pH 7.2, was used
as a test system. 0.1 ml of the erythrocyte suspension
was added per well onto a 96-well plate. Then, 0.1 ml of
TI-complexes at several dilutions was added in 3
repeats. The mixtures were incubated at 37°C for 1 h
and centrifuged at 2000 rpm for 10 min. The superna-
tant was transferred to the wells of a 96-well flat-bot-
tomed plate. Photometry was performed at 540 nm
using an ELX808IU photometer (BioTek Instr., USA) to
determine the minimum effective concentration of the
substance that caused hemolysis in 50% of red blood
cells (HD50).
Adjuvant activity
Laboratory mice (Balb/c strain) with weight of 18-21 g
were used. Animals were keeping in vivarium at stan-
dard conditions with unlimited access to food and water
according with the rules accepted by European Conven-
tion for the Protection of Vertebrate Animals used for
Experimental and Other Scientific Purposes (Strasbourg,
1986). Research was carried out according with the rules
of the proper laboratory practice (GLP), Order of Minis-
try of Health of Russian Federation №267, 19.06.2003
“About the approval of rules for laboratory practice”,
Guide on experimental (pre-clinical) study of new phar-
macological substances” (2005).
The TI-complex was injected at a dose of 1 μg of cucu-
marioside A2-2 and 0.1 μg of YompF or thermostable
toxin per mouse. Immediately before injection, the origi-
nal preparations of antigen-containing TI-complexes
were diluted with PBS, and 10 μl of this solution was
injected subcutaneously into the thighs of the animals.
To study the immunological properties of the TI-com-
plex prototype, pure porin and porin with adjuvants (TI-
complex prototype, ISCOMs or Freund’s complete adju-
vant (Sigma)) were injected intraperitoneally into mice at
doses of 0.1, 1, and 10 μg/mouse in 100 μlo fP B S .
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st and 7
th
day of the experiment. Sera were collected on day 21. In
all experiments each experimental group consisted of 10
animals.
Specific antibodies in blood serum were determined
by the ELISA method. The relative concentration of
antibodies was expressed in optical density units at a
wavelength of 450 nm (dilution of serum - 1/100).
Cytokines (INF-g and IL-1b) were determined in the
blood serum of mice in the respective groups by non-
competitive ELISA using BD OptEIA™ Mouse ELISA
kits (BD, USA). Absorption was recorded with an
Elx808IU microplate photometer, Biotek Instr., USA, at
a wavelength of 450 nm.
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